(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.49%) $79.65
(0.56%) $2.31
(0.57%) $2 353.60
(0.71%) $28.57
(0.47%) $995.50
(0.03%) $0.928
(-0.17%) $10.85
(0.01%) $0.799
(0.02%) $92.56
-1.38% $ 1.430
Live Chart Being Loaded With Signals
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation...
Stats | |
---|---|
Volumen de hoy | 12 407.00 |
Volumen promedio | 162 490 |
Capitalización de mercado | 78.80M |
EPS | $0 ( 2024-04-16 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.320 |
ATR14 | $0.0150 (1.04%) |
Connect Biopharma Correlación
10 Correlaciones Más Positivas | |
---|---|
PWFL | 0.908 |
REPL | 0.884 |
NWLI | 0.883 |
GGAL | 0.881 |
NYMTP | 0.878 |
JOUT | 0.874 |
ANPC | 0.873 |
OM | 0.872 |
SIOX | 0.872 |
AMYT | 0.871 |
10 Correlaciones Más Negativas | |
---|---|
LARK | -0.9 |
HMNF | -0.888 |
RMRM | -0.882 |
PCRX | -0.879 |
THTX | -0.868 |
USCB | -0.866 |
MARK | -0.865 |
SNPX | -0.864 |
SSB | -0.859 |
GOSS | -0.858 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Connect Biopharma Finanzas
Annual | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-14.50 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-14.50 |
Financial Reports:
No articles found.
Connect Biopharma
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico